
Fraxinellone
CAS No. 28808-62-0
Fraxinellone( Fraxinellone )
Catalog No. M18367 CAS No. 28808-62-0
Fraxinellone significantly reduced weight loss and diarrhea in mice and alleviated the macroscopic and microscopic signs of the disease.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 59 | In Stock |
![]() ![]() |
10MG | 87 | In Stock |
![]() ![]() |
25MG | 170 | In Stock |
![]() ![]() |
50MG | 254 | In Stock |
![]() ![]() |
100MG | 382 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameFraxinellone
-
NoteResearch use only, not for human use.
-
Brief DescriptionFraxinellone significantly reduced weight loss and diarrhea in mice and alleviated the macroscopic and microscopic signs of the disease.
-
DescriptionFraxinellone has anti-inflammatory properties. Fraxinellone was found to inhibit LPS-induced nitric oxide (NO) and prostaglandin E(2) (PGE(2)) production, and to reduce the LPS-induced expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the mRNA and protein levels in a dose-dependent manner.
-
In VitroCell Viability Assay Cell Line:A549 cells Concentration:0 μM, 10 μM, 30 μM, 100 μM Incubation Time:12 hours Result:Inhibited the percent of PD-L1 positive cells.
-
In VivoAnimal Model:BALB/c nude miceDosage:30 and 100?mg/kg Administration:Oral gavage; 30 and 100?mg/kg; every three days; 30 daysResult:Significantly suppressed tumor growth.
-
SynonymsFraxinellone
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number28808-62-0
-
Formula Weight232.27
-
Molecular FormulaC14H16O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (430.51 mM)
-
SMILESCC1=C2C(=O)OC(C2(CCC1)C)C3=COC=C3
-
Chemical Name1(3H)-Isobenzofuranone, 3-(3-furanyl)-3a,4,5,6-tetrahydro-3a,7-dimethyl-, (3R-cis)- (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
AGPS-IN-2i
AGPS-IN-2i is a potent and high-affinity inhibitor of alkylglycerol phosphate synthase that controls ether lipid utilization and metabolism in cells, reduces ether lipid levels and cell migration, and promotes proliferation and motility of cancer cells.
-
Lucideric acid A
Lucideric acid A is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation of p38 and JNK/MAPKs activation.
-
S-methyl-KE-298
S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from ?rheumatoid arthritis (RA) synovial cells.